{"id":11874,"date":"2019-03-04T11:26:58","date_gmt":"2019-03-04T03:26:58","guid":{"rendered":"http:\/\/www.namnewsnetwork.org\/?p=11874"},"modified":"2019-03-04T11:27:00","modified_gmt":"2019-03-04T03:27:00","slug":"pantheryx-presents-positive-results-from-two-new-diaresq-studies-at-its-2019-international-scientific-symposium","status":"publish","type":"post","link":"http:\/\/namnewsnetwork.org\/?p=11874","title":{"rendered":"PanTheryx Presents Positive Results from Two New DiaResQ Studies at its 2019 International Scientific Symposium"},"content":{"rendered":"\n<p><strong>BANGKOK, March 4 (Bernama-BUSINESS WIRE) &#8212;<\/strong>\u00a0PanTheryx, a biotechnology company committed to realizing the potential of novel interventions to address a wide range of serious GI microbiome related health conditions, announced today the results of two new studies of its\u00a0<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiaresq.com%2F&amp;esheet=51948992&amp;newsitemid=20190301005607&amp;lan=en-US&amp;anchor=flagship+product+DiaResQ&amp;index=1&amp;md5=b04d5605f91a78dbae9a48b7133690ab\">flagship product DiaResQ<\/a><sup>\u00ae<\/sup>\u00a0at its first annual scientific symposium for clinicians. The symposium titled \u201cDiaResQ: A Scientific Update\u201d presented the findings along with case studies from around the globe. The meeting was held at the Shangri La Hotel in Bangkok over two days, March 1-2.<br><br>According to the World Health Organization, diarrhea is the second leading cause of death for children under five, with an estimated 1.7 billion cases of childhood diarrhea occurring each year. More than 80% of the cases occur in developing countries, including those in Africa and South Asia. Standard of care is limited, and primarily focused on symptom relief and preventing dehydration. <\/p>\n\n\n\n<p><a href=\"http:\/\/mrem.bernama.com\/viewsm.php?idm=33919\">http:\/\/mrem.bernama.com\/viewsm.php?idm=33919<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BANGKOK, March 4 (Bernama-BUSINESS WIRE) &#8212;\u00a0PanTheryx, a biotechnology company committed to realizing the potential of novel interventions to address a wide range of serious GI microbiome related health conditions, announced today the results of two new studies of its\u00a0flagship product DiaResQ\u00ae\u00a0at its first annual scientific symposium for clinicians. The symposium titled \u201cDiaResQ: A Scientific Update\u201d [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[315],"tags":[],"_links":{"self":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/11874"}],"collection":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11874"}],"version-history":[{"count":0,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/11874\/revisions"}],"wp:attachment":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11874"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}